| Low dose interleukin 2 expands plasmablasts with a regulatory b cell phenotype post-MI J O'Brien, A Case, R Sriranjan, ZK Tuong, J Cheriyan, M Clatworthy, ... Atherosclerosis 395, 2024 | | 2024 |
| Role of MAIT cells in atherosclerosis T Radecke, M Chajadine, C Charles, R Al-Rifai, N Mouttoulingam, ... Atherosclerosis 395, 2024 | | 2024 |
| The effect of low-dose interleukin-2 on the T cell receptor landscape in patients with acute myocardial infarction A Case, J O'Brien, R Sriranjan, ZK Tuong, J Cheriyan, M Clatworthy, ... Atherosclerosis 395, 2024 | | 2024 |
| COVID-19 related myocardial injury is associated with immune dysregulation in symptomatic patients with cardiac MRI abnormalities A Ćorović, X Zhao, Y Huang, S Newland, D Gopalan, J Harrison, ... Cardiovascular Research, cvae159, 2024 | | 2024 |
| Therapeutic Avenues to Modulate B-Cell Function in Patients With Cardiovascular Disease JW O’Brien, A Case, C Kemper, TX Zhao, Z Mallat Arteriosclerosis, Thrombosis, and Vascular Biology, 2024 | | 2024 |
| T-Cell/B-Cell Interactions in Atherosclerosis PW Jones, Z Mallat, M Nus Arteriosclerosis, Thrombosis, and Vascular Biology, 2024 | | 2024 |
| THERAPEUTIC AVENUES TO MODULATE B CELL FUNCTION IN PATIENTS WITH CARDIOVASCULAR DISEASE Z Mallat, A Case, J O'Brien, T Zhao, C Kemper American Heart Association, 2024 | | 2024 |
| Century of Milestones and Breakthroughs Related to the Immune Mechanisms of Atherosclerosis Z Mallat, A Tedgui Arteriosclerosis, Thrombosis, and Vascular Biology 44 (5), 1002-1006, 2024 | | 2024 |
| T cell-B cell interactions in atherosclerosis M Nus Chimeno, PW Jones, Z Mallat American Heart Association, 2024 | | 2024 |
| Loss of T follicular regulatory cell–derived IL-1R2 augments germinal center reactions via increased IL-1 K Pyrillou, M Humphry, LA Kitt, A Rodgers, M Nus, MR Bennett, ... JCI insight 9 (5), 2024 | 1 | 2024 |
| Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study–a multicentre … A Low, S van Winden, L Cai, RPC Kessels, MC Maas, RG Morris, M Nus, ... BMJ open 14 (2), e084303, 2024 | | 2024 |
| Marginal zone B cells produce ‘natural’atheroprotective IgM antibodies in a T cell–dependent manner J Harrison, SA Newland, W Jiang, D Giakomidi, X Zhao, M Clement, ... Cardiovascular Research 120 (3), 318-328, 2024 | 10 | 2024 |
| Protocol: Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study–a … A Low, S van Winden, L Cai, RPC Kessels, MC Maas, RG Morris, M Nus, ... BMJ Open 14 (2), 2024 | | 2024 |
| 88. Fostamatinib for the Treatment of Hospitalized Patients With COVID-19 Who Required Oxygen Supplementation: Results of a Phase 3 Trial DB Gotur, A Malik, V Markovtsov, L Yan, W Dummer, Z Mallat Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 004, 2023 | | 2023 |
| Multimodality imaging and immunophenotyping of COVID-19 related myocardial injury (the MIIC-MI Study) A Corovic, X Zhao, Y Huang, D Gopalan, J Harrison, S Chen, ... European Heart Journal 44 (Supplement_2), ehad655. 1796, 2023 | | 2023 |
| PLK1 inhibition dampens NLRP3 inflammasome–elicited response in inflammatory disease models M Baldrighi, C Doreth, Y Li, X Zhao, E Warner, H Chenoweth, K Kishore, ... The Journal of Clinical Investigation 133 (21), 2023 | 1 | 2023 |
| Myocardial inflammation after myocardial infarction: a prospective 68Ga-DOTATATE PET/MRI and immunophenotyping study A Corovic, Y Huang, J Harrison, D Gopalan, J Weir-McCall, A Gallo, ... HEART 109 (SUPPL_ 4), A4-A4, 2023 | | 2023 |
| P05 Myocardial inflammation after myocardial infarction: a prospective 68Ga-DOTATATE PET/MRI and immunophenotyping study A Ćorović, Y Huang, J Harrison, D Gopalan, J Weir-McCall, A Gallo, ... Heart 109 (Suppl 4), A4-A4, 2023 | | 2023 |
| Methods and pharmaceutical compositions for the treatment of obesity F Taleb, Z Mallat, A Tedgui US Patent 11,752,131, 2023 | | 2023 |
| Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis MG Kiss, N Papac-Miličević, F Porsch, D Tsiantoulas, T Hendrikx, ... Immunity 56 (8), 1809-1824. e10, 2023 | 16 | 2023 |
